Search for: "U.S. Pharmaceutical Corporation"
Results 121 - 140
of 1,599
Sorted by Relevance
|
Sort by Date
28 Jan 2016, 6:03 am
In its broadest terms, an inversion is the acquisition of substantially all the assets of a U.S. corporation or partnership by a foreign corporation. [read post]
2 Mar 2019, 10:04 am
Department of Justice, and a member of the U.S. [read post]
10 Mar 2011, 9:15 pm
U.S. [read post]
6 May 2011, 8:37 am
5) Corporate Compliance Insights: FCPA Investigations of Pharmaceutical Industry Abound - In this post, FCPA Professor Mike Koehler discusses the current FCPA sweep underway in the pharmaceutical/medical device industry. [read post]
7 Sep 2022, 6:00 am
Pharmaceutical manufacturer Bayer Corporation and its related entities will pay $40 million to resolve allegations that it violated the False Claims Act. [read post]
26 Mar 2009, 6:17 am
However, it is useful as a guide to the top U.S. research-based (versus generic) drug companies. [read post]
26 Apr 2012, 10:08 pm
Levinson, Inspector General of the U.S. [read post]
11 Sep 2012, 11:55 am
The most successful corporations in the United States view New Jersey's civil justice climate as worse than most, according to a study released by the U.S. [read post]
1 Oct 2010, 4:51 pm
Read the entire U.S. [read post]
5 May 2013, 11:10 am
As part of the 2010 deal, Novartis signed a five-year corporate integrity agreement with the U.S. [read post]
11 Jul 2012, 12:49 pm
Pharmaceutical companies will need to carefully study and consider how to react to “groundbreaking” business practice reforms global health care giant GlaxoSmithKline LLC (“GSK”) has agreed to implement as part of the record $3 billion criminal and civil agreement resolving federal health care fraud and drug marketing charges following its July 2, 2012 guilty plea in U.S. v. [read post]
11 Jul 2012, 12:49 pm
Pharmaceutical companies will need to carefully study and consider how to react to “groundbreaking” business practice reforms global health care giant GlaxoSmithKline LLC (“GSK”) has agreed to implement as part of the record $3 billion criminal and civil agreement resolving federal health care fraud and drug marketing charges following its July 2, 2012 guilty plea in U.S. v. [read post]
11 Jul 2012, 12:49 pm
Pharmaceutical companies will need to carefully study and consider how to react to “groundbreaking” business practice reforms global health care giant GlaxoSmithKline LLC (“GSK”) has agreed to implement as part of the record $3 billion criminal and civil agreement resolving federal health care fraud and drug marketing charges following its July 2, 2012 guilty plea in U.S. v. [read post]
5 May 2021, 1:36 pm
Department of Justice (DOJ) announced that pharmaceutical company Incyte Corporation has agreed to pay $12.6 million to resolve allegations that it violated the False Claims Act. [read post]
25 May 2011, 9:00 pm
Not only will the company benefit from Ireland's 12.5 percent corporate tax rate, it will shield all of its foreign earnings from the U.S.'s worldwide tax system and our high 35 percent corporate tax rate. [read post]
22 Nov 2011, 9:14 am
Synthes actually began testing the products in hospitals during a specific back procedure without prior approval from the U.S. [read post]
5 Nov 2021, 5:21 pm
The U.S. [read post]
5 Nov 2021, 5:21 pm
The U.S. [read post]
26 Mar 2011, 10:17 am
It is another in a spate of gender discrimination lawsuits filed recently against large corporations: last Monday a class action lawsuit was filed against Bayer HealthCare Pharmaceuticals and its parent, Bayer Corp., both U.S. units of Bayer AG, alleging the company has engaged in various discriminatory behaviors against its female employees. (1) The lawsuit, filed in U.S. [read post]
16 Sep 2010, 12:00 pm
The Department of Justice also announced that Forest Pharmaceuticals, Inc. and its parent company, Forest Laboratories, Inc., have agreed to pay $149 million and to enter into a Corporate Integrity Agreement with the Office of Inspector General of the U.S. [read post]
